Background: Endovascular detachable coil embolization has become an important method in the management of intracranial aneurysms. However, coil embolization alone may fail to treat some wide-neck aneurysms. Herein, we report our experience with and outcome of stentassisted coil embolization (SACE) of intracranial aneurysms. Methods: Over a 5-year period, a total of 59 patients diagnosed with 63 intracranial aneurysms underwent SACE. Of the total 63 aneurysms, 6 aneurysms were treated by SACE as a salvageable procedure because of coil instability after detachment. There were 17 men and 42 women enrolled in the study, with ages ranging from 24 to 86 years (mean: 60 years). We retrospectively assessed the clinical data, aneurysm characteristics, and angiographic and clinical outcomes of all patient cases. Results: The mean aneurysm size was 9.4 mm, and the mean neck size was 5.5 mm. Clinical and angiographic follow-up exceeding 6 months were available in 51 and 40 patients, respectively. The mean clinical follow-up time was 28 months (range: 6e49 months). Successful stent deployment was found in 60 aneurysms (95%). Midterm total or subtotal angiographic aneurismal occlusion was obtained in 56 aneurysms (89%), with further thrombosis of the aneurismal sac occurring in 4 (10%). Stable coiling aneurysm was found in 24 (78%), aneurysm recurrence was observed in 5 (13%), and permanent procedural morbidity was observed in two patients (3.4%). During the follow-up period, there were no hemorrhagic events and no stent displacement. Conclusion: Despite a modest procedural complication rate, and some evidence of aneurismal recurrence, SACE was proved to be both effective and safe in managing wide-neck intracranial aneurysms. Our results also demonstrated the midterm durability and stability of aneurysm treated by SACE. Furthermore, SACE can be a salvageable procedure in cases with coil instability after detachment.
Introduction
As shown in an earlier clinical trial, endovascular detachable coil embolization of intracranial aneurysms has become a more widely recognized alternative treatment modality to neurosurgical aneurysm clipping. 1 Despite the increase in clinical experience and improvements in technology, endovascular treatment still has inherent limitations in the management of geographically-difficult intracranial aneurysms such as wide-neck aneurysms. The most common complication of endovascular embolization of wide-neck aneurysm is coil herniation into the parent artery, leading to a thromboembolic event, insufficient aneurysm sac coiling, or to coil compacting with a recurrent aneurysm. 2 Although use of the balloon remodeling technique 3 and use of two-or three-dimensional shaped 4 and bioactive coils or double-catheter technique 5 may help to obtain better morphologic results in the treatment of wide-neck aneurysms, insufficient coil packing and/or recurrence is still a major problem. 3e5 Since the advent of the intracranial stent, stent-assisted coil embolization (SACE) of an aneurysm has the capability to facilitate the management of intracranial wide-neck aneurysms to prevent coil protrusion into the parent vessel, which may allow for the safer and denser packing of the aneurysm sac. 6e8 However, the mid-or long-term effects of SACE of wideneck aneurysms have not been well-evaluated.
The purpose of our study was to report our experience using SACE to manage intracranial aneurysms and to report the midterm outcome of this technique.
Methods
From January 2005 to December 2010, a series of 216 consecutive patients harboring 238 intracranial aneurysms underwent endovascular coil embolization procedure in our institute. Of these, 59 patients with 63 aneurysms underwent SACE because of wide-neck aneurysms (n ¼ 57), with necks larger than 4 mm and/or dome-to-neck ratio greater than 1.5, or SACE as a salvageable procedure (n ¼ 6). There were 17 men and 42 women between the ages of 24e86 years (mean: 60 years). This study was approved by the Institutional Review Board of the Taipei Veterans General Hospital (VGHIRB No: 2010110011A). Information including sex, age distribution, clinical manifestations and characteristics of aneurysms treated by SACE are summarized in Tables 1 and 2 . Of these aneurysms, 25 cases presented with acute subarachnoid hemorrhage (SAH, Fig. 1 ), 12 were nonruptured but clinically symptomatic aneurysms (Fig. 2) , one involved coil compaction with aneurysm recanalization, and four were found by other aneurismal SAH; additionally, 21 were found incidentally (Fig. 3) . The sizes of the aneurysms varied from 2.5 to 26 mm in their maximal dimension (mean: 9.4 mm), and the majority of aneurysms were less than 13 mm (n ¼ 49, 77%). The locations of aneurysms were internal carotid artery (ICA, n ¼ 50, Figs. 1 and 2 ), middle cerebral artery (n ¼ 1), basilar artery (n ¼ 4), vertebral artery (n ¼ 7, Fig. 3 ) or posterior cerebral artery (n ¼ 1).
As for pharmacological therapy, in patients with nonacute SAH, clopidogrel 150 mg and Aspirin 200 mg per day were given for 3 days before embolization; in those patients with acute ruptured aneurysms, a loading dose of clopidogrel 300 mg and Aspirin 300 mg was administered immediately after the procedure. With patients under general anesthesia, the femoral arteries were catheterized by means of a percutaneous technique. A bolus of intravenous heparin was routinely administered after the first or second coil was detached into the aneurismal sac, and we maintained an activated clotting time from 1.5 to 2 times baseline throughout the whole procedure. The 6-or 7-French femoral sheath and guiding catheter were introduced, followed by navigation of a 260 or 300 cm supporting microguide wire into the intracranial branches of ICA or basilar artery. Then, a proper size and length self-expandable Neuroform stent (Boston Scientific/ Target, Fremont, CA, USA) was negotiated into the parent artery to bridge the aneurysm neck. The stent length was chosen to provide at least a 5-mm landing zone beyond the aneurysm neck on the proximal and distal parent artery. The stent was sized to 0.3e0.5 mm greater than the caliber of the parent vessel at the targeted landing zone.
Regarding the technique of aneurysm catheterization, 38 aneurysms were catheterized via stent mesh and coiling after the stent was deployed. In the case of the other 25 aneurysms, the microcatheter was navigated into the aneurysm sac before the stent was deployed (stent-jail catheter, SJT) technique. The selection of aneurysm catheterization largely depended on the location of the aneurysm and on the anatomy of the parent artery. If the aneurysm was evaluated as difficult to catheterize via stent mesh, we preferred to select the SJC technique. After the tip of the microcatheter was stabilized in the aneurismal sac, the proper size and length of detachable coils were placed into the aneurismal sac, one by one, until the aneurismal sac was densely packed. The end of the procedure was determined by the total angiographic obliteration of the aneurismal sac, or by the recoil of the microcatheter into the parent artery due to difficulty of re-entry into the aneurismal sac. Of the 63 aneurysms, six were not initially intended to be treated by SACE. In these particular cases, stenting was selected as a salvageable procedure because of coil herniation or partial migration into the lumen of the parent artery. Under these circumstances, a stent was deployed into the parent artery either to push back the coil into the aneurysm sac or to provide fixation to the partially-migrated coils in between the arterial wall and the stent. Conventional postembolization angiograms were routinely obtained to assess the effect of aneurysm occlusion, the blood flow of the parent artery and its intracranial branches. After the procedure, patients were given intravenous heparinization to keep the active coagulation time (ACT) approximately twice the baseline for 24 hours. We gave clopidogrel 150 mg daily for 2 days, followed by clopidogrel, 75 mg daily for 6 months. A period exceeding 6 months of angiographic and clinical follow-up was obtained in 40 and 53 patients, respectively.
Results
A summary of the data on immediate follow-up angiographies and of procedure-related complications, as well as neurologic outcomes, is presented in Table 3 . Successful stent deployment to an ideal locationdcovering the aneurysm neckdwas observed in 60 of the 63 stents, resulting in a deployment success rate of 95%. In one case, the stent did not reach the proper location due to severe tortuosity of the patient's cavernous internal carotid artery. This patient was alternatively treated by use of the balloon-assisted technique. In two cases, forward jumping of the stent during deployment lead to partial covering of the aneurismal neck, and a second stent was deployed to fully cover the aneurysm neck. After coiling, total occlusion of the aneurysm sac was achieved in 21 cases (33%, Fig. 1 ), subtotal occlusion with small neck remnant or sac filling was accomplished in 35 cases (56%, Figs. 2 and 3), and partial treatment with loose packing was undertaken in six cases (10%). Coiling failure only occurred in one case (2%), but six procedure-related complications were observed (10.2%, Table 3 ). Asymptomatic thromboembolic complications including a dislodged stent with coil herniation or partial migration occurred in four patients. Permanent procedural morbidity was observed in two patients (3.4%). One instance resulted from the coil perforating the aneurysm, and presented with a modified Rankin scale (mRS) 4. The second one had clot formation in the distal M2 of right middle cerebral artery (MCA). Partial recanalization of the MCA was achieved by thrombolytic therapy; ultimately, he suffered from right limb hemiparesis (mRS 2).
Conventional angiography and clinical follow-up extending longer than 6 months was available to 40 and 53 patients, respectively ( Table 3 ). The overall clinical follow-up time ranged from 6 to 49 months (mean: 28 months). During the follow-up period, there were no events of hemorrhage or new events of visual impairment. With regards to the morphologic change of embolized aneurysms, 31 (78%, Figs. 1 and 3) were stable. Further thrombosis of the aneurysm sac occurred in four cases (10%), while coil compaction with recurrent aneurysm was found in five cases (13%). Furthermore, in two cases the aneurysms were larger than 12 mm and retreatment was initiated (Fig. 2) . No evidence of stent displacement or of significant stenosis was found in stenting parent artery. Neurologic outcomes more than 3 months after discharge showed 27 (51%) were mRS 0, 14 (26%) were mRS 1, 9 (17%) were mRS 2, 2 (4%) were mRS 3, and 1 (2%) was mRS 4.
Discussion
In the past, the balloon-mounted stent developed for coronary vessels has been used to assist coil embolization. However, the lack of flexibility necessary to navigate the tortuosities of the carotid siphon may increase the failure rate of the procedure. 2 The advent of the self-expandable intracranial stent, such as the Neuroform stent, has increased the options for treatment of geometrically-difficult aneurysms with wide-neck, unfavorable neck-to-dome ratios, or even fusiform aneurysms, which were traditionally considered unsuitable for detachable coil embolization. The Neuroform stent is made of nickel titanium (nitinol) and has open-cell struts that allow the stent to be more flexible, thus allowing for more distal navigation and permitting the stent to conform its shape to tortuous intracranial arteries.
Theoretically, the application of a stent within the parent vessel for treatment of wide-neck aneurysms has three main advantages. First, the stent can serve as a mechanical scaffold to reconstruct the parent artery for the subsequent coil placement into the aneurysm sac. In this way, the stent prevents coil protrusion into the parent vessel, while also allowing for denser aneurismal packing. Furthermore, there is less chance of coil compaction with aneurismal recurrence. Second, while the stent and its meshes only cover 6.5e9.5% of the internal arterial surface, the intra-aneurysmal flow and velocity may be altered and reduced from 22 to 64% after the stenting. This may indicate favorable progressive thrombosis after stenting.
9,10 Therefore, the hemodynamic alterations caused by the Neuroform stent placement appear to have a positive impact on the long-term durability of coil embolization. The third advantage relates to the stent itself, which may provide a framework for endothelial growth resulting in permanent separation of the aneurysm from the parent vessel lumen.
However, there are some drawbacks of SACE. First of all, the stent is expensive, such that a currently available single Neuroform stent costs about $3800 USD. Moreover, Neuroform stent is almost invisible on the stent itself except its proximal and distal markers. This may make it difficult to ascertain the position of the coil inside the aneurysm sac, or it might even cause a prolapse to the parent artery, particularly in fusiform aneurysms. Another drawback lies in its inability to retract once it is released into the parent artery. This can be particularly important if the stent is deployed to an improper location, as occurred in 2 cases in our series. Furthermore, the stent itself is a metallic foreign body for the parent artery, so it may induce arterial stenosis after stenting. Finally, a premedication and postprocedural antiplatelet regime for several months is necessary in order to prevent a thromboembolic event. In addition to these limitations, navigation of the stent to the tortuous parent artery maybe difficult. In the present series, we successfully navigated 60 of 63 (95%) stents into the targeted location of the parent arteries. One stent was stuck by the ostium of the ophthalmic artery, and the patient was eventually treated using the balloon-assisted technique. Forward jumping of stent was found in 2 patients, and a second stent had to be deployed to fully cover the aneurysm neck. The success rate of stent deployment in our series was comparable with previously published series, which ranged from 92% to 97%. For SACE, clearly there are four strategies regarding the timing of stent navigation and deployment in relation to microcatheter placement and coiling. First, the traditional method is that the stent can be first delivered across the aneurysm neck, and then the microcatheter is placed within the aneurysm sac through the stent mesh. While the majority of reports showed a preference for this technique, in someanatomically difficult aneurysms, transmesh aneurismal catheterization may be difficult to apply given the limitations of the microcatheter' entry angle by the stent mesh. Furthermore, stent movements and dislodgement into the aneurysm sac may be encountered during forceful and/ or multiple attempts to pass the microcatheter through the stent struts. Under these circumstances, the procedure can be interrupted and coil embolization can be delayed for 1 to 2 months. This staged treatment allows for stent stabilization and endothelialization, thus enabling safer catheterization of the aneurysm. 16 Second, the microcatheter can be first placed within the aneurysm sac to allow coil delivery, and then the stent can be positioned and immediately delivered across the aneurysm neck, where the microcatheter is caged between the vessel wall and the stent; this technique is called the SJC technique. This SJC technique permits for the stabilization of the microcatheter during coil delivery. However, this technique may not always be possible 1 (2) mRS: modified Rankin scale (>3 months after discharge).
given that the stent deployment may interfere with the microcatheter position and, in some cases, may pull out the microcatheter from the aneurismal sac. Third, the aneurysm can be coiled using the balloon remodeling technique, and then the stent delivered across the aneurysm neck at the end of the procedure, with the idea of decreasing the recanalization rate. The fourth strategy works under the assumption that stenting can be a salvageable procedure in those aneurismal treatments with coil herniation or partial migration into the parent artery after detachment. Stent deployment has the capacity to push the coil into the aneurysm or to fix the partial migration coil mass in between the stent and wall of the aneurysm. 2, 17 In our series, this procedure was performed in 6 aneurysms.
In terms of timing of the selection of stenting technique used in the presented series, it is largely dependent upon the anatomy of the aneurysm and of the parent artery. If the aneurysm was larger than 8 mm, and presumed to be easy to catheterize such as those aneurysms in the posterior communicating artery, we preferred to deploy the stent first, followed by catheterization via stent mesh. Alternatively, if the aneurysms were smaller, and it was geographically difficult to navigate the microcatheter, we favored the SJC technique. This technique does improve the safety of stent-assisted coiling, especially for small wide-neck aneurysms. When these aneurysms are treated through the original paradigm of first placing a stent, and then catheterizing the aneurysm sac through the stent, there is often a higher likelihood of rupturing the small wide-neck aneurysm because of difficulties associated with passing the catheter through the stent strut. The SJC technique obviates this risk by first securing the microcatheter in place. This technique was particularly suitable for the treatment of small, acutely ruptured aneurysms where only one coil was necessary for adequate occlusion.
Regarding immediate outcomes after postembolization, total and subtotal angiographic aneurysm occlusion were found in 56 aneurysms (89%), which was superior to or comparable with previously published results. Sedat et al 13 reported a 71% total aneurysm sac occlusion rate in 42 aneurysms treated by SACE. Biondi et al 15 reported an 80% rate of total or subtotal occlusion in 42 patients with 45 aneurysms. In the present series, there were 6 aneurysms with partial treatment by loose packing because of either geographically-difficult aneurysms or due to failure of the microcatheter to re-enter the aneurysm sac via stent mesh in case of recoil of microcatheter. In one aneurysm after stenting, negotiation of the microcatheter into the aneurysm was not successful after multiple attempts; fortunately, the aneurysm had total thrombosis at the 13-month angiographic follow-up. In 40 aneurysms with an angiographic follow-up of longer than 6-months, further aneurysm thrombosis occurred in 4 cases (10%), coil compaction with aneurysm recurrence was found in 5 cases (13%) where aneurysms were larger than 12 mm, and retreatment was initiated in 2 cases (5%). The majority of aneurysms (n ¼ 31, 78%) treated by SACE were stable at mid-term follow-up, and no significant parent arterial stenosis induced by the stent itself was demonstrated. These results were different from Lubicz's series. 12 In their 32 cases, where 34 aneurysms were treated by SACE, immediate postembolization images showed only 33% total or subtotal aneurysm occlusion. However, on an average 20-month follow-up, further thrombosis was observed in 18 cases (53%) leading to an aneurysm occlusion rate of up to 86%. Additionally, asymptomatic or nonsignificant in-stent stenosis occurred in 7 patients (22%). The higher percentage of further thrombosis and arterial stenosis can be attributed to the low total and subtotal occlusion rates on immediate postembolization, longer angiographic follow-up time (20 vs. 11 months) and use of a lower dosage of post-treatment antiplatelet regime (160 mg Aspirin vs. 75 mg clopidogrel) in Lubicz's series. In terms of neurological outcomes after more than 3 months (Table 3 , n ¼ 53), they are dependent upon the patient's initial clinical presentation, such as ruptured or nonrupture aneurysms, delayed cerebrovascular ischemia, and/or procedure-related complications. In our series, all patients with nonruptured aneurysms had mRS 0-1, except one patient who had a procedure-related aneurysm rupture leading to moderately severe disability (mRS 4). In those patients with acute aneurismal SAH, the clinical outcomes were varied and were related to the initial brain injury and/or presence of delayed cerebrovascular ischemia, as well as procedure-related complication. Procedure-related complication occurred in seven cases (12%). Of these, asymptomatic stent dislodgement (n ¼ 2) and thromboembolic events (n ¼ 3) was found in 5 cases, while one case presented with limb paresis attributable to partial occlusion of the middle cerebral artery; acute coil perforation with aneurysm rupture was demonstrated in 1 case, leading to permanent neurologic defect. Therefore, procedure-related permanent neurologic deficit was found in two patients (3.4%) in the presented series, which was comparable or better than those of previously published results (which range from 2.4% to 7.4%). 6,10e15 In conclusion, despite a low rate of procedural complications, and some evidence of coil compaction with recurrent aneurysm occurring in cases with larger aneurysms, SACE was proven to be both effective and safe in managing wideneck intracranial aneurysms. Our results also demonstrated the mid-term durability and stability of aneurysms treated by SACE. Furthermore, stenting can be a salvageable procedure in cases with coil herniation or partial migration into the parent artery.
